The story of 3M in the second quarter of 2026 is a diversified industrial conglomerate that is becoming smaller and cleaner, but is paying for the cleanup along the way. Revenue of $6.5 billion rose a modest amount on a reported basis. The more flattering read is the adjusted organic growth of 5.4%, which captures industrial, safety, semiconductor, and data center end markets accelerating even as consumer electronics and a manufactured PFAS product exit weighed on the top line. The headline number for the equity sits in the gap between GAAP earnings per share of $1.78 and adjusted earnings per share of $2.40. That $0.62 gap is driven mostly by a $336 million loss on the Dyneon divestiture. Transformation costs add roughly $100 million. Those transformation costs are treated by management as outside the run-rate business. Behind those adjusting items, the underlying earnings power is healthier than the GAAP print suggests, even after tariffs and the post-Solventum cost dis-synergies continue to drag reported margins below the company's long-term target.
The price action reflects the same split personality. MMM closed in the high $160s, with a fifty-two week range running from the low $130s into the mid $180s and a market capitalization near $87 billion. The valuation looks rich on a trailing earnings basis at roughly thirty times reported earnings, but that multiple is distorted by special items; on forward and adjusted earnings the multiple compresses into the high teens, in line with a diversified industrial that is supposed to grow in the mid-single digits and return most of its free cash. The dividend was raised 7% to $0.78 per share in February and held at that level in May. It now sits at roughly a 1.8% yield and has been paid for 110 consecutive years. That unbroken record is one of the equity's quiet selling points even in a year of litigation drag.
The forward case turns on three things that the management discussion lays out explicitly. First, whether the Safety and Industrial segment can keep compounding organic growth near 8% as electrical markets, abrasives, industrial adhesives, and personal safety continue to expand. Second, whether Transportation and Electronics can translate semiconductor, aerospace, and data center demand into margin recovery rather than just revenue growth, given that segment's second-quarter margin slipped despite a 6% top-line gain. Third, whether the PFAS payment schedule under the PWS Settlement, combined with the newly proposed New Jersey Settlement and a still-unresolved Combat Arms litigation overhang, can be paid down without forcing another leg of leverage or a meaningful dividend cut. The most important counterargument is that even after a year of restructuring, the GAAP earnings line still shows transformation, divestiture, and litigation noise that an investor cannot ignore, which is why the case for owning the equity at the current multiple depends on confidence that the adjusted picture is the right one to underwrite.